In 2016 in a study by Bai et al., CXCR3 IHC was examined in FFPE tissues of 71 CRC-II patients whose tumour recurred, 72 non-recurrent CRC-II patients and 10 healthy samples (from the peritumoral region) [60]. The gene discussed is CXCR3; the disease is neoplasm.